phase I clinical study
Incendia Therapeutics' DDR1 Inhibitor Advances to Phase Ic Trial
The company has identified an optimal dose and potential biomarkers of response to PRTH-101 in the Phase I trial.
Relay Advancing Mutant PI3Kα Inhibitor into Phase III Breast Cancer Trial
The company said interim data from a Phase I trial of RLY-2608 plus fulvestrant support moving the program into a pivotal study in 2025.
Epsilogen Raises $16.4M in Series B Expansion to Support Ovarian Cancer Drug Study
The firm will begin a Phase Ib trial exploring its MOv18 immunoglobulin E antibody in folate receptor alpha-positive ovarian cancer.
PolTreg T-Regulatory Cell Therapy Shows Clinical Remission in Type 1 Diabetes for up to 12 Years
The company is now seeking partnership funding to launch a pivotal Phase II/III study of the autologous T-regulatory cell therapy.
Promising 12-Month Data on Atsena's LCA1 Gene Therapy Bolsters Case of Pivotal Trial
The latest safety and efficacy Phase I/II data on ATSN-101 support moving the gene therapy into a randomized Phase III trial.
Aug 27, 2024